The 20 Best Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors Near Me in Ann Arbor, MI

Find the Top Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Experts and Specialists

Last Updated: 04/28/2026

Save doctors for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Already have a doctor?
Find A Second Opinion

MediFind found 51 doctor with experience in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) near Ann Arbor, MI. Of these, 34 are Experienced, 10 are Advanced and 7 are Distinguished.

Location
LocationClose
51 providers found
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine | Radiology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine | Radiology

    U Of M Radiology Nuclear Medicine

    1500 E Medical Center Dr, Spc 5000, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Richard Brown is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), and Melorheostosis. Dr. Brown is board certified in Diagnostic Radiology, Nuclear Medicine, and Nuclear Radiology.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Neuroradiology | Radiology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Neuroradiology | Radiology

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Dr. Srinivasan went to medical school in Chennai, India and pursued radiology residency at the All India Institute Medical Sciences in New Delhi. Subsequently, he did a Neuroradiology fellowship at the University of Ottawa in Canada and then joined as faculty at the University of Michigan in Ann Arbor, USA. He is presently Director of the Neuroradiology division and Associate Professor of Radiology at the University of Michigan. He received the RSNA research scholar award from 2008-2010 for his project titled ‘Creation of prediction model for response to chemoradiation in head and neck squamous cell carcinoma’. He has published over 60 papers, written 8 book chapters and presented over 90 scientific or educational presentations at national and international conferences. He is a frequent speaker at national radiology and neuroradiology conferences in the US including the American Roentgen Ray Society and the American society of Head and Neck Radiology. He presently serves on the editorial board on the Head and neck section of two premier radiology journals “Radiology” and “European Radiology”. Dr. Srinivasan is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Stroke, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Synovial Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Thrombectomy.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Neuroradiology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Neuroradiology

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Gaurang Shah is a Radiologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Stroke, Sciatica, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Relapsing Multiple Sclerosis (RMS). Dr. Shah is board certified in Diagnostic Radiology and Neuroradiology.

    Learn about our expert tiers
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Cardiology | Internal Medicine
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Cardiology | Internal Medicine

    U Of M Cardiology

    24 Frank Lloyd Wright Dr, 
    Ann Arbor, MI 
     (4.0 miles away)
    Languages Spoken:
    English

    Dr. Yamada has been practicing medicine and cardiology for over 20 years. She has expertise in echocardiography which has allowed her to better understand, diagnose and treat cardiac disease. Her clinical and research interests include: cardiology oncology and the relationship between cancer treatment and heart disease; the role of echocardiography in understanding different cardiac pathologies and treatments; mitral valve disease; atrial fibrillation and general cardiology. Dr. Yamada launched the Cardio-Oncology clinic at the UMHS Cardiovascular Center in 2011, after a period of training at the MD Anderson Cancer Center. In this clinic, she evaluates patients who have cancer and are either at risk, or have developed cardiac disease as a complication of cancer treatment. Her goal in this clinic is to prevent, early diagnose and treat cardiac toxicity from cancer treatment, and to optimize underlying heart condition prior to cancer therapy. Dr. Yamada is also interested in helping childhood cancer survivors prevent heart complications from cancer treatment. Dr. Yamada is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Arrhythmias, and Doxorubicin-Induced Cardiomyopathy. Dr. Yamada is board certified in Cardiovascular Disease.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Anil Attili is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Attili is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adrenal Cancer, Lung Nodules, Rhabdomyosarcoma Embryonal, and Cardiac Ablation.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Oncology | Hematology | Internal Medicine
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Oncology | Hematology | Internal Medicine

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception A, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pathology | Hematology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pathology | Hematology

    U Of M Pathology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Nuclear Medicine
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Nuclear Medicine

    University Hospital

    1500 E Medical Center Dr, Floor B1 Reception C, 
    Ann Arbor, MI 
     (0.8 miles away)
    Experience:
    17+ years
    Languages Spoken:
    English

    Benjamin Viglianti is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Viglianti is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Osteopenia, Melorheostosis with Osteopoikilosis, and Melorheostosis. Dr. Viglianti is board certified in Diagnostic Radiology and Nuclear Medicine.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatric Cardiology | Pediatrics | Internal Medicine
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatric Cardiology | Pediatrics | Internal Medicine

    Frankel Cardiovascular Center

    1425 E Ann St, Floor 3 Reception C, 
    Ann Arbor, MI 
     (0.6 miles away)
    Languages Spoken:
    English

    Mark Norris is a Pediatrics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Norris is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Congenital Heart Disease (CHD), Tetralogy of Fallot, Double Outlet Left Ventricle, and Truncus Arteriosus.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Cardiology | Internal Medicine
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Cardiology | Internal Medicine

    Frankel Cardiovascular Center

    1425 E Ann St, Floor 3 Reception C, 
    Ann Arbor, MI 
     (0.6 miles away)
    Languages Spoken:
    English

    William Armstrong is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Armstrong is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Aortic Valve Stenosis, Cardiac Ablation, and Pacemaker Implantation. Dr. Armstrong is board certified in Internal Medicine and Cardiovascular Disease.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatric Cardiology | Pediatrics
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatric Cardiology | Pediatrics

    C. S. Mott Children's Hospital

    1540 E Hospital Dr, Floor 11 Reception C, 
    Ann Arbor, MI 
     (0.7 miles away)
    Languages Spoken:
    English

    Thor Thorsson is a Pediatrics specialist and a Pediatric Cardiologist practicing medicine in Ann Arbor, Michigan. Dr. Thorsson is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 107 other conditions, according to our data. His clinical expertise encompasses Tetralogy of Fallot, Hypoplastic Left Heart Syndrome (HLHS), Mitral Atresia, and Isthmian Coarctation. Dr. Thorsson is board certified in Pediatric Cardiology.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatric Cardiology | Pediatrics | Internal Medicine
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatric Cardiology | Pediatrics | Internal Medicine

    C. S. Mott Children's Hospital

    1540 E Hospital Dr, Floor 11 Reception C, 
    Ann Arbor, MI 
     (0.7 miles away)
    Languages Spoken:
    English

    Heang Lim is a Pediatrics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Lim is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hypoplastic Left Heart Syndrome (HLHS), Mitral Atresia, Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and Heart Transplant. Dr. Lim is board certified in Pediatrics and Pediatric Cardiology.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    University Hospital

    1500 E Medical Center Dr, Floor B1 Reception C, 
    Ann Arbor, MI 
     (0.8 miles away)
    Experience:
    10+ years
    Languages Spoken:
    English

    Molly Roseland is a Radiologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Roseland is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia. Dr. Roseland is board certified in Diagnostic Radiology and Nuclear Medicine.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception E, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Mishal Mendiratta is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Mendiratta is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Visceromegaly, and Cholangiocarcinoma (Bile Duct Cancer).

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Pediatric Radiology
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Pediatric Radiology

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Gary Luker is a Radiologist and a Pediatric Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Luker is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Tracheoesophageal Fistula, Posterior Urethral Valves, Chondrodystrophy, and Hepato-Pancreato-Biliary Surgery. Dr. Luker is board certified in Diagnostic Radiology and Pediatric Radiology.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatrics
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pediatrics

    C. S. Mott Children's Hospital

    1540 E Hospital Dr, Floor 7 Reception C, 
    Ann Arbor, MI 
     (0.7 miles away)
    Languages Spoken:
    English

    Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology | Internal Medicine
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology | Internal Medicine

    C. S. Mott Children's Hospital

    1540 E Hospital Dr, Floor 7 Reception B, 
    Ann Arbor, MI 
     (0.7 miles away)
    Languages Spoken:
    English
    Offers Telehealth

    Attaphol Pawarode is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Pawarode is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology | Internal Medicine
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology | Internal Medicine

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception A, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English
    Offers Telehealth

    Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine | Neurology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine | Neurology

    University Hospital

    1500 E Medical Center Dr, Floor B1 Reception C, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology | Internal Medicine
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology | Internal Medicine

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception A, 
    Ann Arbor, MI 
     (0.8 miles away)
    Languages Spoken:
    English

    Scott Gitlin is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Gitlin is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Hemangioma Thrombocytopenia Syndrome.

    Showing 1-20 of 51

    Last Updated: 04/28/2026

    When should I see a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor near Ann Arbor, MI?

    There are various reasons why you may want to see a specialist, such as: 

    • Your primary care provider recommends it. 
    • Your condition requires expert knowledge and specialized care. 
    • Your symptoms persist or worsen despite treatment. 
    • You need specialized testing or procedures. 
    • You want a second opinion.  

    What should I consider when choosing a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor near Ann Arbor, MI?

    It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.  

    How does MediFind rank Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctors near Ann Arbor, MI?

    MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database. 

    What types of insurance are accepted by Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctors near Ann Arbor, MI?

    Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network. 

    How can I book an appointment online with a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor near Ann Arbor, MI?

    MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor search results page. 

    Why is it important to get a second opinion from a different Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor?

    Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.   

    How can I prepare for my appointment with a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor near Ann Arbor, MI?

    Prepare for your appointment by gathering the following items: 

    • Copies of medical records (dating back at least one year) 
    • Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see 
    • Family history of disease 
    • List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses 
    • Allergies to medications, food, latex, insects, etc.  
    • List of questions and concerns 
    • Your insurance card 

    You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit. 

    What questions should I ask my Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor?

    Here are some sample questions: 

    • Can you explain in simple terms what this condition is and how it’s treated? 
    • What symptoms or side effects should I watch for? 
    • What tests will be involved, and when can I expect results? 
    • Are there other specialists I need to see? 
    • What’s the best way to reach you if I have follow-up questions? 

    How can I learn about the latest clinical trials and research advances my Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor may know about?

    MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you. 

    MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand. 

    Can I filter my search to show male or female Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctors near Ann Arbor, MI?

    Look for the filter feature on the left side of the Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers. 

    Can I filter my search to find a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor that offers video calls?

    Look for the filter feature on the left-side of the Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls). 

    Reviewed on: 11/11/24  

    By: MediFind Medical Staff 

    Read more about our Content Policy

    More Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors by city